Alyeska Investment Group’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-131,250	Closed	-$3.18M	–	573
2022 Q1	$3.18M	Buy	131,250 +6,250	+5%	+$152K	0.04%	354
2021 Q4	$4.03M	Hold	125,000	–	–	0.05%	315
2021 Q3	$5.59M	Buy	+125,000	New	+$5.59M	0.07%	304